Chan; Bryan K.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Chan; Bryan K..The latest application filed is for "cinnoline compounds and uses thereof".
- Chan; Bryan K. - Foster City CA
- Chan; Bryan K. - South San Francisco CA
- Chan; Bryan K. - San Carlos CA
- Chan; Bryan K. - Burlingame CA
- Chan, Bryan K. - Redwood City CA
| Patent | Date |
|---|---|
| Cinnoline Compounds And Uses Thereof App 20220073520 - Malhotra; Sushant ; et al. | 2022-03-10 |
| Naphthyridine Compounds And Uses Thereof App 20210277024 - Kellar; Terry ; et al. | 2021-09-09 |
| Isoquinoline Compounds And Uses Thereof App 20210253580 - Liang; Jun ; et al. | 2021-08-19 |
| Pyrazole aminopyrimidine derivatives as LRRK2 modulators Grant 9,212,173 - Baker-Glenn , et al. December 15, 2 | 2015-12-15 |
| Bicyclic pyrazole LRRK2 small molecule inhibitors Grant 9,212,186 - Baker-Glenn , et al. December 15, 2 | 2015-12-15 |
| Aminopyrimidine derivatives as LRRK2 modulators Grant 9,145,402 - Baker-Glenn , et al. September 29, 2 | 2015-09-29 |
| Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (PET) imaging for LRRK2 Grant 9,139,566 - Marik , et al. September 22, 2 | 2015-09-22 |
| Bicyclic Pyrazole Lrrk2 Small Molecule Inhibitors App 20150051201 - Baker-Glenn; Charles ; et al. | 2015-02-19 |
| Pyrazole Aminopyrimidine Derivatives As Lrrk2 Modulators App 20150051238 - Baker-Glenn; Charles ; et al. | 2015-02-19 |
| Pyrazole aminopyrimidine derivatives as LRRK2 modulators Grant 8,815,882 - Baker-Glenn , et al. August 26, 2 | 2014-08-26 |
| Aminopyrimidine derivatives as LRRK2 modulators Grant 8,809,331 - Baker-Glenn , et al. August 19, 2 | 2014-08-19 |
| Aminopyrimidine derivatives as LRRK2 modulators Grant 8,802,674 - Baker-Glenn , et al. August 12, 2 | 2014-08-12 |
| Aminopyrimidine derivatives as LRRK2 modulators Grant 8,796,296 - Baker-Glenn , et al. August 5, 2 | 2014-08-05 |
| Aminopyrimidine derivatives as LRRK2 modulators Grant 8,791,130 - Baker-Glenn , et al. July 29, 2 | 2014-07-29 |
| Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK Grant 8,569,281 - Chan , et al. October 29, 2 | 2013-10-29 |
| Aminopyrimidine Derivatives As Lrrk2 Modulators App 20130157999 - Baker-Glenn; Charles ; et al. | 2013-06-20 |
| Fluorine-18 And Carbon-11 Labeled Radioligands For Positron Emission Tomography (pet) Imaging For Lrrk2 App 20130156700 - Marik; Jan ; et al. | 2013-06-20 |
| Aminopyrimidine Derivatives As Lrrk2 Modulators App 20130158057 - Baker-Glenn; Charles ; et al. | 2013-06-20 |
| Aminopyrimidine Derivatives As Lrrk2 Modulators App 20130158006 - Baker-Glenn; Charles ; et al. | 2013-06-20 |
| Aminopyrimidine Derivatives As Lrrk2 Modulators App 20130158032 - Baker-Glenn; Charles ; et al. | 2013-06-20 |
| Aminopyrimidine Derivatives As Lrrk2 Modulators App 20130096102 - Baker-Glenn; Charles ; et al. | 2013-04-18 |
| Aminopyrimidine derivatives as LRRK2 inhibitors Grant 8,354,420 - Baker-Glenn , et al. January 15, 2 | 2013-01-15 |
| Compounds App 20120295883 - CHAN; Bryan K. ; et al. | 2012-11-22 |
| Pyrazole Aminopyrimidine Derivatives As Lrrk2 Modulators App 20120157427 - Baker-Glenn; Charles ; et al. | 2012-06-21 |
| Aminopyrimidine Derivatives As Lrrk2 Inhibitors App 20110301141 - Baker-Glenn; Charles ; et al. | 2011-12-08 |
| Method and system for managing chronic disease and wellness online App 20010039503 - Chan, Bryan K. ; et al. | 2001-11-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 